Issues in the Conduct of Economic Evaluations of Pharmaceutical Products
- 1 November 1994
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 6 (5), 405-411
- https://doi.org/10.2165/00019053-199406050-00001
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysisHealth Economics, 1994
- Conflict of interest. International Committee of Medical Journal Writers.1993
- Regulation of the Pharmaceutical IndustryPharmacoEconomics, 1992
- Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1992
- Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status?Health Economics, 1992
- Economic Analysis in Randomized Control TrialsMedical Care, 1992
- Cost-Effectiveness and Cost-Benefit Analyses in the Medical LiteratureAnnals of Internal Medicine, 1992
- Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1992
- Farewell to promoting goodbuys?The Lancet, 1991
- Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical CompaniesNew England Journal of Medicine, 1991